State of the art in surgery for early stage NSCLC—does the number of resected lymph nodes matter?

Surgery is the treatment of choice in patients with early stage NSCLC. However, results remain poor in these patients, with 5-year survival rates ranging from 84% in stage I to 39% in stage IIIA, according to different studies (1)